Navigation Links
Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines
Date:12/24/2013

A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines recommending routine opt-out HIV testing in all health care settings, according to a study appearing in the December 25 issue of JAMA.

"Opioid dependence is a risk factor for HIV, STIs, and hepatitis C virus (HCV) infection. Opioid treatment programs, which provide treatment to more than 300,000 opioid-dependent individuals in the United States, are well-positioned to offer testing for these infectious diseases to a high-risk population. They were among the first venues to offer HIV testing and are more likely to offer HIV, STI, and HCV testing than other drug treatment programs. Private for-profit opioid treatment programs are increasingly widespread and such programs offer on-site HIV testing less often than nonprofit and public programs. However, with the 2006 national recommendations for routine opt-out HIV testing, we hypothesized that the percentage of programs offering on-site testing for HIV, STIs, and HCV would increase," the authors write.

Marcus A. Bachhuber, M.D., and Chinazo O. Cunningham, M.D., M.S., of the Albert Einstein College of Medicine, New York, analyzed data from a survey sent to directors of drug treatment facilities and tabulated the percentage of opioid treatment programs offering on-site HIV, STI, and HCV testing from 2000 to 2011.

The number of U.S. opioid treatment programs increased from 849 in 2000 to 1,175 in 2011. The percentage of programs operating as for-profit businesses increased from 43 percent to 54 percent, nonprofits decreased from 43 percent to 36 percent, and public programs decreased from 14 percent to 10 percent. From 2000 to 2011, the absolute number of programs offering testing for HIV, STIs, and HCV increased but the percentage offering on-site testing for HIV declined by 18 percent and for STIs by 13 percent. There was no change for HCV testing. More than 75 percent of public programs offered on-site testing for each infection, with no change over time.

"Declines were most pronounced in for-profit programs, suggesting that persons enrolled in these programs may be at increased risk for delayed diagnosis and continued transmission of HIV, STIs, and HCV," the authors write.

"Opioid treatment programs are important venues for offering testing to high-risk individuals. As the number of for-profit opioid treatment programs increases, and the opioid, HIV, and HCV epidemics continue to intersect, further work is needed to understand and reverse declines in offering on-site testing."


'/>"/>

Contact: Kim Newman
Sciencenews@einstein.yu.edu
718-430-3101
The JAMA Network Journals
Source:Eurekalert

Related medicine news :

1. Infections cause lower proportion of lead extractions than expected
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Eye and Vision Diseases are at Epidemic Proportions
4. Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions
5. Higher proportion of California children uninsured than in US, USC analysis shows
6. Cigarette Taxes Disproportionately Burden the Poor, Report Says
7. Elder abuse affects Latinos disproportionately
8. VitaPro Labs Launches New Withdrawal Aid System at WithdrawalAid.com, a Supplement Proven To Ease Opioid Withdrawal Symptoms
9. Prescription opioid abusers prefer to get high on oxycodone and hydrocodone
10. Modern Medical’s Opioid Defense Manager Sees Measureable Results in Just 12 Months.
11. Avoiding Addiction When Powerful Opioid Painkillers Are Needed, From the November 2013 Harvard Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... ... Photoprotective Technologies (PPT) has just received US patent 10/357,124 for its HEV Melanin ... such as creams or makeup and is distributed by Vantage Specialty Ingredients under a ... from blue light as well as UV. , Melanin - Nature’s Sunscreen., Melanin ...
(Date:8/21/2019)... ... August 21, 2019 , ... Future residents ... 28. The Phase II expansion of Providence Point in Pittsburgh’s Scott Township neighborhood ... construction of the 70-unit apartment tower, Hamilton Tower. , The expansion ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... million medically necessary and cosmetic procedures in 2018 – 7.5 percent more than ... year, the 2018 ASDS Survey on Dermatologic Procedures revealed skin cancer ...
(Date:8/19/2019)... , ... August 19, 2019 , ... A July 26 ... dog owners should be brushing their pets’ teeth twice a day. The acknowledges that, ... the time and suggests that close monitoring and brushing at least twice a week ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... free dental care services today under a program sponsored by United Concordia Dental ... are proud to work alongside them to make these services available to area ...
Breaking Medicine News(10 mins):
(Date:8/17/2019)... ... August 17, 2019 , ... Inc. ... Foster Crown, LLC Ranks No. 2502 on the 2019 Inc. 5000 with Three-Year ... LLC, the boutique physician recruitment firm is No. 2502 on its annual Inc. ...
(Date:8/16/2019)... Calif. (PRWEB) , ... August 16, 2019 , ... Sacramento-based ... company in the United States by Inc. magazine. MDstaffers three-year growth of more ... ranked it as the fastest growing human resources company had it competed in this ...
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... time to prepare the kids for returning to the classroom. The National ... so these students can join their friends free of lice and their nits ...
Breaking Medicine Technology: